About

I joined the University in September 2022. My background is with health sciences and nursing, and I am in the World’s top 2% of scientists (Oncology) as per Stanford University list (2021).

I have worked through all academic ranks from Lecturer (University of Liverpool) to Senior Lecturer (University of Nottingham) to Reader and then Professor (University of Manchester). Followed by Chair Professor and Head of School for a decade at the Hong Kong Polytechnic University.

I have secured more than £10 million pounds of research funding from competitive sources (ie. DoH; NCRI; NIHR RfPB; Marie Curie Cancer Care etc) in the UK and Hong Kong (Health & Medical research Fund; Health Bureau) plus international collaborative grants. I have more than 350 publications, and an h-index of H-index of (Aug 2022): 51 (WoS) or 77 (Google Scholar) [Aug 2022], having the highest h-index in my profession in the UK, and the top 10 internationally. Some of the publications are in prestigious journals like Lancet, Lancet Oncology or Journal of Clinical Oncology.

I have done consultancies with the World Health Organisation (WHO) in Cambodia, Fiji and Philippines, developed reports for WHO on rural ageing services and contributed to WHO policy documents (ie. on COVID-19 and long-term care facilities) and I have been Director of a WHO Collaborating centre for a decade. I am Editor-in-Chief of the European Journal of Oncology Nursing since January 2003 (this is one of only four international peer-reviewed cancer nursing journals. Impact factor of 2.398), and Editor of special issues in Frontiers in Oncology (with Impact factor of 6.244). I have also graduated more than 20 PhD students and attracted funding for and supervised several post-doc fellows. I am executive board member ins several international professional societies and associations.

I have or had Visiting/Honorary/Adjunct Professorships in the below institutions:

• Honorary Professor, King’s College London, UK. 2019-ongoing.
• Adjunct Professor, University of Technology Sydney, Australia. Jan 2016-ongoing
• Foreign Adjunct Professor of Nursing, Karolinska Institute, Stockholm, Sweden. July 2016-ongoing.
• Adjunct Professor, Charles Darwin University, Darwin, Australia. March 2022 – ongoing.
• Adjunct Professor, James Cook University, Cairns, Australia. Sept 2016 – 2022.
• Adjunct Professor, Affiliated Hospital of the Southwest Medical University, Luzhou, China. 2018- ongoing.
• Jiangnan University, Wuxi Medical School, Wuxi, China. 2013-ongoing.
• National University of Singapore, Singapore. 2010-2013.
• Wits University, Johannesburg, South Africa. 2011-2015
• Fujian University of Traditional Chinese Medicine, Fuzhou, China, 2015-ongoing
• Australian Catholic University, Sydney, Australia. 2006-2008
• Zynyi Medical University, Zhuhai, China, 2016-2017
• University of Sichuan, Chengdu, China, 2017-2021.

In terms of leadership, as a Head of School and Dean of Nursing in my last position, I managed to move the school in and up the international rankings. Within 4 years from starting my headship the school became a listed school in the specialty QS ranking, entering as 43 in the world (2017), moving up to number 31 in 2020. In summer 2022, The Shanghai International ranking put as at number 21 in the world.

Other achievements include:

• tripling the 3*/4* papers in the 2021 RAE exercise; meeting most KPI of the University; leading on the completion and successful run of the new health science campus in Sichuan, China (with the nursing programmes being the only ones that the Ministry of Education approved for continuation beyond the original agreement)
• improved the success rate in external grants from 10% to average of 45%, also diversifying research income and enhancing quality of publications
• increasing research income by 430%
• focusing on improving the student experience in a strategic way with concrete measures
• developed a network of international collaborations with leading institutions
• increased undergraduate student mobility (from 14 in 2012 to 200-250 annually currently) and expanded the network of international student exchange partners
• re-organised all postgraduate programmes in a more coherent and cost-effective manner; focused on MOOC development (one is at the top 10 most popular courses as per MIT platform)
• negotiated and developed a Dual Masters programme in Disaster Management with the University of Manchester
• established (in 2018) the Greater Bay Area Nursing Research & Knowledge Transfer Alliance, bringing together 7 Universities and clinical partners across HK, Macau, Zhuhai, Shenzhen and Guangzhou (area covering 60 million people) to work together (with the Ministry of Health in China and Health Bureau in HK selecting this as one of the 10 most important health initiatives in the region (in 2019)
• enhanced interdisciplinary collaboration within the faculty and internationally; brought the Red Cross into the campus to develop a blood transfusion service (currently providing 3,500 units of blood each year)
• developed a new minor programme in Traditional Chinese Medicinal Nursing alongside the BSc Nursing (Hons) programme, a first in the world, among others.

Teaching responsibilities

• Research Methodology (Trials/quantitative designs)
• Integrative health
• Cancer and palliative care

Professional interests

I am a Registered Nurse with further training in counselling; integrative health and acupuncture; and lymphedema therapy. I have a strong and active research profile that I will continue in my PVC/Dean role through current and new external grants, supervision of PhD students and directing programmes of research within Arts and Health.

My health background in a College of Arts, Humanities and Education will allow me to work with colleagues across Colleges and the University alongside my strong national and international network of collaborators. I am strong proponent of inter- and trans-disciplinary work.

I am board member of international societies and I am involved or leading on the development or updates of international clinical guidelines on cancer symptoms. I am involved as board member with many journals. I provide consultation to government agencies internationally or chair external review boards on department/school wide academic evaluations.

I am also part of an international consortium on research (lead University of Malmo where I act as international consultant). I review research grant applications for many agencies (incl. in UK, HK, Australia, Canada, South Africa), and I have been chairman of review panels for the Health and Medical Research Fund in Hong Kong for several years. I have been global advisor for several industry partners. I have been board member in NHS Trust committees.

I have also worked to attract donation both for research and for student support initiatives (and I have secured to date more than the equivalent of £3M). I have led and organised multiple international conferences. I am often invited around the globe to talk about both education and practice related topic, and I have delivered many key note speeches and invited talks in international conferences over the years.

Research interests

My research interests are around art and health, particularly how therapeutic art can improve symptoms in cancer an palliative care patients.

Supportive and palliative care, with more focus on symptom management and developing non-pharmacological interventions. Key symptom foci include:

• chemotherapy-related nausea and vomiting
• breathlessness and cough in lung cancer
• symptom clusters
• cancer-related peripheral neuropathy
• ageing

Qualifications

• BSc, MSc (Hull),
• PhD (Birmingham)
• RN/RGN

Additional interests and activities

Examples of research impact

1. Work on Chemotherapy-induced Nausea and Vomiting (CINV)

Publications:

Molassiotis A, Aapro M, Dicato M, Gascon P, Novoa SA, Isambert N, Burke TA, Gu A, Roila F. Evaluation of risk factors predicting chemotherapy-related nausea and vomiting: results from a European prospective observational study. J Pain Symptom Manage. 2014;47(5):839-848.

Dranitsaris G, Molassiotis A, Clemons M, Roeland E, Schwartzberg L, Dielenseger P, Jordan K, Young A, Aapro M. The development of a prediction tool to identify cancer patients at high risk for chemotherapy-induced nausea and vomiting. Ann Oncol. 2017 Jun 1;28(6):1260-1267.

Molassiotis A, Lee PH, Burke TA, Dicato M, Gascon P, Roila F, Aapro M. Anticipatory Nausea, Risk Factors, and Its Impact on Chemotherapy-Induced Nausea and Vomiting: Results From the Pan European Emesis Registry Study. J Pain Symptom Manage. 2016 Jun;51(6):987-93.

Impact:

The risk prediction model study for chemotherapy-induced nausea and vomiting (CINV) led to the development of a website and an app for use by clinicians to calculate CINV risk in patients before chemotherapy begins (www.riskcinv.org ) and is hosted by an industry partner (Helsinn Pharma; released in late 2018). Usability data of this new online tool show that a significant number of clinicians across several countries are using it. Further to this online risk assessment tool, our team developed a number of symptom management tools including the antiemesis scale (MAT) which is now available on Apple store as an app (https://itunes.apple.com/us/app/mascc-antiemesis-tool-mat/id536500719?mt=8  ), and as an android app in Google Play supported by Merck & Co. These apps are available free-of-charge for use by clinicians to aid clinical decision-making and improve communication with patients. The MAT is also used as a primary outcome measure in a large number of international antiemetic trials and observational studies (as per www.clinicaltrial.gov information), including currently in USA, France, Italy and international trials being translated in 16 languages (https://www.mascc.org/mat ). The research on anticipatory nausea in chemotherapy patients and the risk factor research have also been used in the Antiemetic Guidelines of the Multinational Association of Supportive Care in Cancer (MASCC) and the European Society of Medical Oncology (ESMO) in 2016 (societies with a combined membership of >5,000 clinicians). Use/uptake of antiemetic guidelines according to several studies is around 30%, suggesting that at least one-third of chemotherapy patients in western countries have improved antiemetic control as a result of these guidelines.

Evidence:

MASCC/ESMO International clinical guidelines where our research is cited, reaching >5,000 clinician members and a large (but unknown) number through its free availability/access of the guidelines

https://www.esmo.org/Guidelines/Supportive-and-Palliative-Care/MASCC-and-ESMO-Consensus-Guidelines-for-the-Prevention-of-Chemotherapy-and-Radiotherapy-Induced-Nausea-and-Vomiting

American Society of Clinical Oncology (ASCO) webcasts disseminating information on our studies and sharing key results of our work, with findings reaching >50,000 ASCO members

http://www.ascopost.com/issues/august-10-2016/more-focus-needed-on-chemotherapy-induced-nausea-as-a-cluster-of-symptoms/  

 2. Influence on clinical guidelines

Publications:

Molassiotis A, Brunton L, Hodgetts J, Green AC, Beesley VL, Mulatero C, Newton-Bishop JA, Lorigan P. Prevalence and correlates of unmet supportive care needs in patients with resected invasive cutaneous melanoma. Ann Oncol. 2014;25(10):2052-8.

Molassiotis A, Bailey C, Caress A, Tan JY. Interventions for cough in cancer. Cochrane Database Syst Rev. 2015 May 19;5:CD007881

Impact:

Our work has been incorporated in the UK’s NICE guidance on ‘Melanoma: assessment and treatment’ (2015). In addition, our work on cough related to lung cancer has been embedded into the 2017 guidelines on lung cancer of the American College of Chest Physicians (ACCP), which has been highly cited. Cough is present in 85% and is a distressing symptom in 65% of the 2 million people diagnosed with lung cancer in the world each year. These CHEST guidelines have wide reach, not only to the 50,000 chest physicians receiving the Chest Journal and the CHEST guidelines open-access website where this is also listed, but also by endorsement (as stated in the journal website) by the following societies: American College of Allergy, Asthma and Immunology; American Thoracic Society; Asian Pacific Society of Respirology; Canadian Thoracic Society; Irish Thoracic Society.

Evidence:

NICE guidance. Melanoma: assessment and treatment (2015). Citations in p54 and p.56 from our research. Influencing relevant section of standards of care.

https://www.nice.org.uk/guidance/ng14/evidence/full-guideline-pdf-250314589  

American College of Chest Physicians (ACCP), CHEST clinical guidelines on cough in lung cancer. Used as standard of care.

https://journal.chestnet.org/article/S0012-3692(17)30022-3/fulltext 

3. Work in Integrative Medicine

Publications

1. Liu XL, Tan JY, Molassiotis A, Suen LK, Shi Y. Acupuncture-point stimulation for postoperative pain control: a systematic review and meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med. 2015;2015:657809 doi: 10.1155/2015/657809.
2. Molassiotis A, Bardy J, Finnegan-John J, Mackereth P, et al. Acupuncture for Cancer-Related Fatigue in Patients With Breast Cancer: A Pragmatic Randomized Controlled Trial. J Clin Oncol. 2012 Dec 20;30(36):4470-6.
3. Molassiotis A, Russell W, Hughes J, Breckons M, Lloyd-Williams M, Richardson J, Hulme C, Brearley SG, Campbell M, Garrow A, Ryder WD. The effectiveness of acupressure for the control and management of chemotherapy-related acute and delayed nausea: a randomized controlled trial. J Pain Symptom Manage. 2014;47(1):12-25
4. Molassiotis A, Charalambous A, Taylor P, Stamataki Z, Summers Y. The effect of resistance inspiratory muscle training in the management of breathlessness in patients with thoracic malignancies: a feasibility randomised trial. Support Care Cancer. 2015 Jun;23(6):1637-45.
5. Molassiotis A, Suen LKP, Cheng HL, et al. A Randomized Assessor-Blinded Wait-List-Controlled Trial to Assess the Effectiveness of Acupuncture in the Management of Chemotherapy-Induced Peripheral Neuropathy. Integr Cancer Ther 2019; 18:1534735419836501.

Impact

As a result of our clinical trials of acupuncture (ie. ref.2 and two others from the team) have been included in the clinical guidelines of the International (29 countries) Society for Integrative Oncology] reaching more than 1,000 society members and a large number through the open-access publication. The same reference is listed under the Memorial Sloan Kettering Cancer Centre’s ‘Acupuncture’ service, as part of the evidence presented to patients. Ref 3 is further included in the National Comprehensive Cancer Network (NCCN) antiemetic guidelines, reaching its >50,000 members and a strong advocacy service-user group, as well as USA’s National Guideline Clearing House, Agency of Healthcare Research & Quality. Also, our related work has been incorporated in patient information websites and professional websites such as that of the USA Oncology Nursing Society accessed by >10,000 members. Our work also has been used as patient information leaflets from the USA National Cancer Institute. The National Cancer Institute in USA has cited our work in its Physician Data Query series on ‘Acupuncture’, a comprehensive source of cancer information available to clinicians and patients worldwide through its open-access document. Reference 1 was used as part of the evidence submitted by the Academic Consortium for Integrative Medicine & Health in the USA to the USA’s Department of Health & Human Services, on the latter’s consultation for the management of pain in adults. Since then key recommendations were adopted in all hospitals in the US. Reference 5 is key to the clinical guidelines of the American Society of Clinical Oncology (ASCO) in their latest update for the management of chemotherapy-induced peripheral neuropathy, as is ref. 4 for ASCO’s clinical guidelines for the management of dyspnea in advanced cancer patients.

Evidence:

Clinical Practice Guidelines on Integrative Therapies in Cancer, where our work is cited.

1. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411539/
2. https://www.mskcc.org/cancer-care/integrative-medicine/therapies/acupuncture

National Comprehensive Cancer Network clinical guidelines where our work is cited, reaching >50,000 members

1. https://www.scribd.com/doc/300008118/antiemesis-NCCN
2. https://www.cancer.gov/about-cancer/treatment/side-effects/nausea/nausea-hp-pdq (patient information leaflets from the USA National Cancer institute)

Research findings from the team cited in international patient websites https://www.asbestos.com/blog/2015/05/27/acupressure-points-for-cancer/  

and professional websites (such as from the Oncology Nursing Society) https://www.ons.org/node/1311?topic=761   

National Cancer Institute’s in USA citing our work in its Physician Data Query series on ‘Acupuncture’, a comprehensive source of cancer information available to clinicians and patients worldwide through its open-access document

https://www.cancer.gov/about-cancer/treatment/cam/hp/acupuncture-pdq  

Evidence submitted by the Academic Consortium for Integrative Medicine & Health in the USA to the USA’s Department of Health & Human Services, on the latter’s consultation for the management of pain in adults where are work (ref 1) is cited

https://s3.amazonaws.com/imconsortium/wp-content/uploads/2019/04/01194647/HHS-Comments-from-The-Consortium-April-1-2019.pdf  

American Society of Clinical Oncology (ASCO) webcasts disseminating information on our studies and sharing key results of our work, with findings reaching >50,000 ASCO members

http://www.ascopost.com/issues/august-10-2016/more-focus-needed-on-chemotherapy-induced-nausea-as-a-cluster-of-symptoms/  

 https://ascopubs.org/doi/10.1200/JCO.20.01399 

 https://ascopubs.org/doi/full/10.1200/JCO.20.03465      

Recent publications

GBD 2019 Ageing Collaborators. Global, regional, and national burden of diseases and injuries for adults 70 years and older: systematic analysis for the Global Burden of Disease 2019 Study. BMJ. 2022 Mar 10;376:e068208. doi: 10.1136/bmj-2021-068208. [Impact factor: 39.890]

GBD 2019 Cancer Risk Factors Collaborators. The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2022 Aug 20;400(10352):563-591.

Wang T, Huang YY, Liu XL, Molassiotis A, Yao LQ, Zheng SL, Tan JB, Huang HQ. Prevalence and correlates of joint pain among Chinese breast cancer survivors receiving aromatase inhibitor treatment. Support Care Cancer. 2022 Sep 6. doi: 10.1007/s00520-022-07345-3.

Liang MZ, Tang Y, Knobf MT, Molassiotis A, Chen P, Hu GY, Sun Z, Yu YL, Ye ZJ. Resilience index improves prediction of 1-year decreased quality of life in breast cancer. Journal of Cancer Survivorship. 2022 Aug 6.(in press). [Impact factor: 4.062] 

Abu-Odah H, Su J, Wang M, Lin SR, Bayuo J, Musa SS, Molassiotis A. Palliative Care Landscape in the COVID-19 Era: Bibliometric Analysis of Global Research. Healthcare (Basel). 2022 Jul 20;10(7):1344. [Impact factor: 3.16] 

Wang M, Bandla A, Sundar R, Molassiotis A. The phenotype and value of nerve conduction studies in measuring chemotherapy-induced peripheral neuropathy: a secondary analysis of pooled data. European Journal of Oncology Nursing.(in press). [Impact factor: 2.58] 

Lekdamrongkul P, Pongthavornkamol K, Molassiotis A, Dechpichai P, Pinsuntorn P. Translation and psychometric testing of the Thai version of cancer survivors' unmet needs measure among cancer survivors. Asia Pacific Journal of Oncology Nursing. 2022 May 18;9(9):100083.

Yang HL, Mo B, Molassiotis A, Wang M , He G , Xie YJ. Relationship between multimorbidity and composite lifestyle status in Shenzhen, China. Journal of Multimorbidity and Comorbidity (in press).

Montayre J, Foster J, Zhao IY, Kong A, Leung AYM, Molassiotis A, Officer A, Mikton C, Neville S. Age-friendly interventions in rural and remote areas: A scoping review. Australasian Journal of Ageing. 2022 doi: 10.1111/ajag.13101. Epub ahead of print. [Impact factor: 1.87]

Abu-Odah H, Molassiotis A, Yat Wa Liu J. Analysis of the unmet needs of Palestinian advanced cancer patients and their relationship to emotional distress: results from a cross-sectional study. BMC Palliative Care. 2022; 21(1):72. [Impact factor: 3.113]

Deng SY, Zhao IY, Ho MH, Saravanakumar P, Molassiotis A, Montayre J. Rural-urban disparities in healthy ageing: Evidence from a national study in China. Collegian 2022 (in press).

Wang M, Pei Z, Molassiotis A. Recent advances in managing chemotherapy-induced peripheral neuropathy: A systematic review. European Journal of Oncology Nursing. 2022 Mar 26; 58:102134. doi: 10.1016/j.ejon.2022.102134. [Impact factor: 2.398]  Epub ahead of print.

Wang M, Yin Y, Yang H, Pei Z, Molassiotis A. Evaluating the safety, feasibility, and efficacy of non-invasive neuromodulation techniques in chemotherapy-induced peripheral neuropathy: A systematic review. European Journal of Oncology Nursing. 2022; 58:102124. [Impact factor: 2.58] 

Su JJ, Lin RSY, Paguio J, Leung AYM, Molassiotis A. Palliative Care for Older Adults Hospitalized for Stroke From the Informal Caregivers' Perspectives: A Qualitative Study. Journal of Cardiovascular Nursing. 2022 Apr 29.(in press).

Leung AYM, Su JJ, Lee ESH, Fung JTS, Molassiotis A. Intrinsic capacity of older people in the community using WHO Integrated Care for Older People (ICOPE) framework: a cross-sectional study. BMC Geriatrics. 2022;22(1):304. doi: 10.1186/s12877-022-02980-1. [Impact factor: 3.921]

Molassiotis A, Kwok SWH, Leung AYM, Tyrovolas S. Associations between sociodemographic factors, health spending, disease burden, and life expectancy of older adults (70 + years old) in 22 countries in the Western Pacific Region, 1995-2019: estimates from the Global Burden of Disease (GBD) Study 2019. Geroscience. 2022. doi: 10.1007/s11357-021-00494-z (in press). [Impact factor: 7.713]

Leen AJ, Yap DWT, Teo CB, Tan BKJ, Molassiotis A, Ishiguro H, Fan SWX, Sundar R, Soon YY, Bandla A. A Systematic Review and Meta-Analysis of the Effectiveness of Neuroprotectants for Paclitaxel-Induced Peripheral Neuropathy. Frontiers in Oncology. 2022 (in press) doi: 10.3389/fonc.2021.763229. [Impact factor: 6.244]

Abu-Odah H, Molassiotis A, Liu JYW. Gathering policymakers’ perspectives as an essential step in planning and implementing palliative care services at a national level: an example from a resource-limited country. BMC Palliative Care 21, 43 (2022). https://doi.org/10.1186/s12904-022-00936-1. [Impact factor: 3.234]

Molassiotis A, Guo C, West C, Loke AY. Identifying the priorities in nursing research on disaster management: A Delphi study and international survey. International Journal of Disaster Risk Reduction (in press). [Impact factor: 4.32]

Tan JY, Molassiotis A, Suen LKP, Liu J, Wang T, Huang HR. Effects of auricular acupressure on chemotherapy-induced nausea and vomiting in breast cancer patients: a preliminary randomized controlled trial. BMC Complementary Medicine & Therapies. 2022; 22(1):87. doi: 10.1186/s12906-022-03543-y. [Impact factor: 3.659]

Abu-Odah H, Molassiotis A, Liu JYW. Assessment of the Educational and Health Care System-Related Issues From Physicians' and Nurses' Perspectives Before Developing a Palliative Care Program Within the Palestinian Health Care System: A Cross-sectional Study. Journal of Hospice & Palliative Nursing. 2022 (in press). doi: 10.1097/NJH.0000000000000840. [Impact factor: 1.918]

Molassiotis A, Wang M. Understanding and Supporting Informal Cancer Caregivers. Current Treatment Options in Oncology. 2022. (in press) doi: 10.1007/s11864-022-00955-3. [Impact factor: 5.036]

Zheng Y, Molassiotis A, Tyrovolas S, Yip PSF. Epidemiological changes, demographic drivers, and global years of life lost from suicide over the period 1990-2019. Suicide and Life-Threatening Behavior 2022 (in press). [Impact factor: 4.450]

Wang M, Molassiotis A. Mapping chemotherapy-induced peripheral neuropathy phenotype and health-related quality of life in patients with cancer through exploratory analysis of multimodal assessment data. Supportive Care in Cancer 2022, 30(5):4007-4017. [Impact factor: 3.603]

Said N, Molassiotis A, Chiang VCL. Psychological first aid training in disaster preparedness for nurses working with emergencies and traumas. International Nursing Review 2022 (in press). [Impact factor: 2.871]

Liu XL, Huang YY, Wang T, Molassiotis A, Yao LQ, Huang HQ, Zheng SL, Tan JY. Psychometric assessment of the Chinese version of the Oxford Knee Score in breast cancer survivors experiencing hormone treatment-related knee dysfunction. Asia-Pacific Journal of Oncology Nursing 2022 (in press). [Impact factor: 2.509]

Molassiotis A, Tyrovolas S, Yeo W, Gine-Vazquez I, Aapro M, Herrstedt J. Organized breast cancer screening not only reduces mortality from breast cancer but more so significantly decreases years living with disability: analysis of the Global Burden of Disease Study and screening programme availability in 130 countries. ESMO Open 2021, 6(3): 100111 doi:10.1016/j.esmoop.2021.100111  [Impact factor: 6.540]

Leung DYP, Cheng HL, Tyrovolas S, Tang ASK, Liu JYW, Tse MMY, Lai CKY, Molassiotis A. Magnitude, Temporal Trends, and Inequalities in the DALYs and YLDs of Nutritional Deficiency among Older Adults in the Western Pacific Region: Findings from the Global Burden of Disease Study 1990-2019. Nutrients. 2021;13(12):4421. doi: 10.3390/nu13124421. [impact factor: 5.719]

Tyrovolas S, Giné-Vázquez I, Fernández D, Morena M, Koyanagi A, Janko M, Haro JM, Lin Y, Lee P, Pan W, Panagiotakos D, Molassiotis A. Estimating the COVID-19 spread through real-time population mobility patterns: surveillance in Low- and Middle- income countries. Journal of Medical Internet Research 2021, 23(6): e22999. doi: 10.2196/22999. [Impact factor: 5.03]

Yeo W, Mo FKF, Yip CCH, Yeo VA, Li L, Lau TKH, Lai KT, Chan VTC, Wong KH, Pang E, Cheung M, Chan V, Kwok CCH, Suen JJS, Molassiotis A. Quality of Life Associated with Nausea and Vomiting from Anthracycline-Based Chemotherapy: A Pooled Data Analysis from Three Prospective Trials. The Oncologist. 2021, 26(12): e2288-e2296. doi: 10.1002/onco.13978. [impact factor: 5.550]

GBD 2019 Respiratory Tract Cancers Collaborators. Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Respiratory Medicine 2021; 9(9):1030-1049. doi: 10.1016/S2213-2600(21)00164-8. [impact factor: 30.700]

Abu-Odah H, Molassiotis A, Liu JYW. Global palliative care research (2002-2020): bibliometric review and mapping analysis. BMJ Supportive & Palliative Care 2021. doi: 10.1136/bmjspcare-2021-002982. Epub ahead of print. [impact factor: 3.568]

Molassiotis A, Leung AYM, Zhao IY. Call for urgent actions in societies and health systems in the Western Pacific Region. Journal of the American Geriatrics Society 2021, 69(8): 2374-2377. [impact factor: 5.562]

Cheng HL, Molassiotis A, Leung KT, Wong KH. Docetaxel-induced peripheral neuropathy in breast cancer patients treated with adjuvant or neo-adjuvant chemotherapy. Breast Care 2021, 16(3): 269-275. [Impact factor: 2.860]

Kinyoki D, Osgood-Zimmerman AE, Bhattacharjee NV; Local Burden of Disease Anaemia Collaborators, Kassebaum NJ, Hay SI. Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018. Nature Medicine 2021, 27(10): 1761-1782. [impact factor: 53.44]

Wong RS, Tung KT, Fu KW, Bacon-Shone J, Molasiotis A, Li WO, Lee LY, Lum TY, Lau JT, Chan C, To SM, Ip P. Examining social context and the pathways to mental wellness in young adults during social movement: A parallel mediation analysis. Journal of Affective Disorders 2021; 294:876-882. [impact factor: 4.839]

Leung AYM, Molassiotis A, Carino DA. A challenge to healthy ageing: Limited social participation in old age. Aging & Disease 2021; 12(7): 1536-1538. [impact factor: 6.745]

Zhao YI, Ma YX, Yu MWC, Liu J, Dong WN, Pang Q, Lu XQ, Molassiotis A, Holroyd E, Wong CWW. Ethics, Integrity and Retributions of Digital Detection Surveillance Systems on Infectious Diseases: Systematic literature review. Journal of Medical Internet Research 2021, 23(10): e32328. doi: 10.2196/32328. [Impact factor: 5.43]

Yung JYK, Wong V, Ho GWK, Molassiotis A. Understanding the experiences of hikikomori through the lens of the CHIME framework: connectedness, hope and optimism, identity, meaning in life, and empowerment; systematic review. BMC Psychology 2021; 9(1):104. doi: 10.1186/s40359-021-00605-7.

Wang T, Molassiotis A, Tan Y-Y; Chung BPM. A qualitative exploration of the unmet information needs of Chinese advanced cancer patients and their informal caregivers. BMC Palliative Care 20, 83 (2021). https://doi.org/10.1186/s12904-021-00774-7 [impact factor: 3.234]

Chan CW, Molassiotis A, Lee HKK. Antimicrobial prophylaxis and post-chemotherapy neutropenic fever in patients with leukemia: comparisons of C-reactive protein, procalcitonin and immediate fever outcome measures between those with and without prophylaxis, and the implications for practice. Supportive Care in Cancer 2021, 29(12): 7515-7523. doi: 10.1007/s00520-021-06325-3. [Impact factor: 3.603]

Hoang HTX, Molassiotis A, Chan CW, Vu HA, Bui TP. Pilot randomized sham-controlled trial of self-acupressure to manage the symptom cluster of insomnia, depression, and anxiety in cancer patients undergoing chemotherapy. Sleep and Breathing 2021 (in press). [Impact factor: 2.816]

Lekdamrongkul P, Pongthavornkamol K, Molassiotis A, Sriyuktasuth A, Siritanaratkul N, Chansatitporn N. Exploring Health-Related Quality of Life Among Non-Hodgkin’s Lymphoma Survivors After Completion of Primary Treatment: A Cross-Sectional Study in Thailand. Supportive Care in Cancer 2021, 29(11): 6511-6522. [Impact factor: 3.603]

Amoah PA, Leung AYM, Lloyd Parial L, Poon ACY, Tong HHY, Ng WI, Li X, Wong EML, Kor PPK, Molassiotis A. Digital health literacy and health-related well-being amid the COVID-19 pandemic: the role of socioeconomic status among university students in Hong Kong and Macao. Asia Pacific Journal of Public Health 2021, 33(5): 613-616. [impact factor: 1.399]

Molassiotis A, Guo C, Abu Odah H, West C, Loke AY. Evolution of disaster nursing research in the past 30 years (1990 -2019): A bibliometric and mapping analysis. International Journal of Disaster Risk Reduction. 2021, 58: 102230. [Impact factor: 4.32]

Molassiotis A, Vu VD, Ching S. The effectiveness of qigong in managing a cluster of symptoms (breathlessness-fatigue-anxiety) in patients with lung cancer: a randomized controlled trial. Integrative Cancer Therapies 2021, 20: 15347354211008253. [Impact factor: 3.279]

Molassiotis A, Brown T, Cheng HL, Byrnes A, Chan RJ, Wyld D, Eastgate M, Yates P, Marshall AP, Fichera R, Isenring L, To KF, Ko PS, Lam W, Lam YF, Au LF, Lo RS. The effects of a family-centered psychosocial-based nutrition intervention in patients with advanced cancer: the PiCNIC2 pilot randomised controlled trial. Nutrition Journal 2021; 20(1):2. doi: 10.1186/s12937-020-00657-2. [Impact factor: 3.359]

Herrstedt J, Molassiotis A. Teaching supportive care: what is the core curriculum? Current Opinions in Oncology 2021, 33(4): 279-286. [Impact factor: 3.336]

Loke AY, Guo C, Molassiotis A. Development of Disaster Nursing Education and Training Programs in the Past 20 Years (2000-2019): A Systematic Review. Nurse Education Today 2021, 99: 104809. [impact factor: 3.442]

Abu-Odah H, Molassiotis A, Liu J. Lessons Learned from Countries that Have Introduced Palliative Care Services into Their National Health System: A Narrative Review. Journal of Palliative Care 2021, 37(1):55-66. [Impact factor: 2.250]

Kor PPK, Leung AYM, Parial LL, Wong EML, Dadaczynski K, Okan O, Amoah PA, Wang SS, Deng R, Cheung TCC, Molassiotis A. Are People With Chronic Diseases Satisfied With the Online Health Information Related to COVID-19 During the Pandemic? Journal of Nursing Scholarship 2021; 53(1):75-86. [Impact factor: 3.176]

Molassiotis A, Liu XL, Kwok SW. Impact of advanced nursing practice through nurse-led clinics in the care of cancer patients: A scoping review. European Journal of Cancer Care 2020, 9:e13358. doi: 10.1111/ecc.13358. [Impact factor: 2.520]

Smith JA, Harle A, Dockry R, Holt K, Russell P, Molassiotis A, Yorke J, Robinson R, Birrell MA, Belvisi MG, Blackhall F. Aprepitant For Cough in Lung Cancer: A Randomised Placebo-Controlled Trial and Mechanistic Insights. American Journal of Respiratory and Critical Care Medicine 2021, 203(6):737-745. [Impact factor: 21.4]

Molassiotis A, Fraser A, Culligan M, Labuc P, Csaba DL, Charalambous A. Nursing and allied health research priorities in the care of patients with thoracic malignancies: An international cross-sectional survey. Frontiers in Oncology 2020, 10:591799. doi: 10.3389/fonc.2020.591799  [Impact factor: 6.244]

Wang T, Molassiotis A, Tan Y-Y; Chung BPM; Huang HQ. Prevalence and correlates of unmet palliative care needs in dyads of Chinese patients with advanced cancer and their informal caregivers: A cross-sectional survey. Supportive Care in Cancer 2021, 29: 1683-1689. [Impact factor: 3.603]

Molassiotis A, Dawkins B, Longo R, Suen LKP, Cheng HL, Mok T, , Hulme C, Yeo W. Economic evaluation alongside a randomised controlled trial to assess the effectiveness and cost-effectiveness of acupuncture in the management of chemotherapy-induced peripheral neuropathy. Acupuncture in Medicine 2021, 39: 41-52. [Impact factor: 2.267]

Tan JY, Liu J, Suen LKP, Molassiotis A, Wang T. Development and validation of an evidence-based auricular acupressure intervention for managing chemotherapy-induced nausea and vomiting in breast cancer patients. Complementary Therapies in Medicine. 2020; 52:102502. doi: 10.1016/j.ctim.2020.102502. [Impact factor: 2.446]

Ericsson A, Carlson E, Ching SS, Molassiotis A, Kumlien C. Partners' experiences of living with men who have screening-detected abdominal aortic aneurysms: A qualitative descriptive study. Journal of Clinical Nursing. 2020, 29(19-20):3711-3720. [Impact factor: 3.036]

Marshall AP, Tobiano G, Roberts S, Isenring E, Sanmugarajah J, Kiefer D, Fulton R, Cheng HL, To KF, Ko PS, Lam YF, Lam W, Molassiotis A. End-user perceptions of a patient-and family-centred intervention to improve nutrition intake among oncology patients: A descriptive qualitative analysis. BMC Nutrition 2020; 6:29. doi: 10.1186/s40795-020-00353-8. [Impact factor: 2.700]

Cheng HL, Lopez V, Lam S, Leung KT, Li YC, Wong KH, Au JSK, Sundar R, Chan A, De Ng T, Suen L, Chan CW, Yorke J, Molassiotis A. Psychometric testing of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group—Neurotoxicity subscale in a longitudinal study of cancer patients treated with chemotherapy. Health and Quality of Life Outcomes 2020; 18(1):246. doi: 10.1186/s12955-020-01493-y. [Impact factor: 3.186]

Tyrovolas S, El Bcheraoui C, Alghnam SA, Alhabib KF, Almadi MAH, Al-Raddadi RM, Bedi N, El Tantawi M, Krish VS, Memish ZA, Mohammad Y, Molassiotis A, Panagiotakos D, Salam N, Sobaih BH, Mokdad AH. GBD 2017 Saudi Arabia Collaborators. The Burden of Disease in Saudi Arabia 1990-2017: Results From the Global Burden of Disease Study 2017. Lancet Planetary Health 2020; 4(5):e195-e208. doi: 10.1016/S2542-5196(20)30075-9. [Impact factor: 19.173]

Molassiotis A, Wang T, Huong TXH, Tang JY, Yamamoto-Mitani N, Cheng K, Tuazon J; Kunaviktikul W, Suen L. Doctoral Nursing Education in East and Southeast Asia: Characteristics of the Programs and Students’ Experiences of and Satisfaction with their Studies. BMC Medical Education 2020; 20(1):143. doi: 10.1186/s12909-020-02060-1. [Impact factor: 2.463]

Farrell C, Chan EA, Siouta E, Walshe C, Molassiotis A. Communication patterns in nurse-led chemotherapy clinics: A mixed-method study. Patient Education and Counselling. 2020, 103(8):1538-1545. [Impact factor: 2.94]

Harle A, Molassiotis A, Buffin O, Burnham J, Smith J, Yorke J, Blackhall FH. A cross sectional study to determine the prevalence of cough and its impact in patients with lung cancer: a patient unmet need. BMC Cancer. 2020; 20(1):9. doi: 10.1186/s12885-019-6451-1. [Impact factor: 4.430]

Leung AYM, Molassiotis A, Zhang J, Deng R, Liu M, Van IK, Leong CSU, Leung ISH, Leung, DYP, Lin X, Loke AY. Dementia literacy in Greater Bay Area, China: Identifying the at-risk population and the preferred mass media for receiving dementia information. International Journal of Environmental Research & Public Health 2020, 7; 17(7). pii: E2511. doi: 10.3390/ijerph17072511. [Impact factor: 3.390]

Xie  YJ, Cheung  D, Yuen Loke  A, Lam Nogueira B, Ming Liu K, Leung AYM, Tsang A, Leong C, Molasiotis A. Relationships Between Television Viewing, Computer and Mobile Phone Usage and Sleep Quality in a Chinese Population: A Community-Based Cross-Sectional Study. Journal of Medical Internet Research 2020, 7;22(7):e18095. doi: 10.2196/18095. [Impact factor: 5.43]

Abu-Odah H, Molassiotis A, Liu J. Challenges on the provision of palliative care for patients with cancer in low- and middle-income countries: a systematic review of reviews. BMC Palliative Care 2020; 19(1):55. doi: 10.1186/s12904-020-00558-5. [Impact factor: 3.234]

Wong CL, So WKW, Choi KC, Tong M, Choy YP, Molassiotis A, Yates P, Chan RJ. Oncology Nurses' Perspectives and Practices Toward the Delivery of Cancer Survivorship Care in Hong Kong. Cancer Nursing 2021, 44(4):295-304. [Impact factor: 2.816]

Said NB, Molassiotis A, Chiang VCL. Psychological preparedness for disasters among nurses with disaster field experience: An international online survey. International Journal of Disaster Risk Reduction, 2020, 46, 101533. [Impact factor: 4.32]

Hoang HTX, Molassiotis A, Chan CW, Nguyen TH, Liep Nguyen V. New-onset insomnia among cancer patients undergoing chemotherapy: prevalence, risk factors, and its correlation with other symptoms. Sleep & Breathing. 2020, 24(1), 241-251. [Impact factor: 2.816]

Chow R, Bruera E, Arends J, Walsh D, Strasser F, Isenring E, Del Fabbro EG, Molassiotis A, Krishnan M, Chiu L, Chiu N, Chan S, Tang TY, Lam H, Lock M, DeAngelis C. Enteral and parenteral nutrition in cancer patients, a comparison of complication rates: an updated systematic review and (cumulative) meta-analysis. Supportive Care in Cancer. 2020, 28(3): 979-1010. [Impact factor: 3.603]

Marx W, McCarthy A, Marshall S, Crichton M, Molassiotis A, Ried K, Bird R, Lohning A, Isenring E. Supplemental prophylactic intervention for chemotherapy-induced nausea and emesis (SPICE) trial: Protocol for a multicentre double-blind placebo-controlled randomised trial. Nutrition & Dietetics. 2020; 77(1):144-150. [Impact factor: 1.742]

Chan CW, Hong Lee P, Molassiotis A, Kwok Kuen Lee H. Symptom Clusters in Post-chemotherapy Neutropenic Fever in Hematological Malignancy: Associations Among Sickness Behavior Symptom Cluster, Inflammatory Biomarkers of Procalcitonin and C-reactive protein, and Febrile Measures. Journal of Pain & Symptom Management. 2020, 59(6):1204-1211. [Impact factor: 3.612]

Wang M, Cheng HL, Lopez V, Sundar R, Yorke J, Molassiotis A. Redefining chemotherapy-induced peripheral neuropathy through symptom cluster analysis and patient-reported outcome data over time. BMC Cancer. 2019; 19(1):1151. doi: 10.1186/s12885-019-6352-3. [Impact factor: 4.430]

Zhao S, Dong H, Qin J, Liu H, Li Y, Chen Y, Molassiotis A, He D, Lin G, Yang L. Breast cancer mortality in Chinese women: Does migrant status play a role? Annals of Epidemiology 2019; 40:28-34. [Impact factor: 2.573]

Leung AYM, Leung SF, Ho GWK, Bressington D, Molassiotis A, Lam C, Ligot J, Valdez LP, Lazalita A, Chhit S, Chou P, Valimaki M. Dementia Literacy in Western Pacific Countries: A mixed-methods study. International Journal of Geriatric Psychiatry. 2019. 34(12):1815-1825. [Impact factor: 2.675]

Wang T, Molassiotis A, Chung BPM, Tan JY. Psychometric assessment of the Chinese version of the Problems and Needs in Palliative Care questionnaire-short version in advanced cancer patients. BMC Palliative Care. 2019 Aug 6;18(1):68. doi: 10.1186/s12904-019-0450-5. [Impact factor: 2.015]

Luckett T, Phillips J, Currow DC, Agar M, Molassiotis A. Cough in lung cancer: A survey of current practice among Australian health professionals. Collegian 2019, 26: 629-633. [Impact factor: 1.83]

Suen LKP, Molassiotis A, Yueng SKW, Yeh CH. Comparison of Magnetic Auriculotherapy, Laser Auriculotherapy and Their Combination for Treatment of Insomnia in the Elderly: A Double-Blinded Randomised Trial. Evidence Based Complementary & Alternative Medicine. 2019, 21;2019:3651268. [Impact factor: 1.813]

Molassiotis A, Suen LKP, Cheng HL, Mok TSK, Lee SCY, Wang CH, Lee P, Leung H, Chan V, Lau TKH, Yeo W. A Randomized Assessor-Blinded Wait-List-Controlled Trial to Assess the Effectiveness of Acupuncture in the Management of Chemotherapy-Induced Peripheral Neuropathy. Integrative Cancer Therapies. 2019,;18:1534735419836501. doi: 10.1177/1534735419836501. [Impact factor: 2.379]

Siouta E, Farrell C, Chan EA, Walshe C, Molassiotis A. Communicative constructions of person-centred and non-person-centred caring in nurse-led consultations. European Journal of Oncology Nursing. 2019; 40:10-21. [Impact factor: 1.876]

Pongthavornkamol K, Lekdamrongkul P, Pinsuntorn P, Molassiotis A. Physical Symptoms, Unmet Needs, and Quality of Life in Thai Cancer Survivors after the Completion of Primary Treatment. Asia-Pacific Journal of Oncology Nursing 2019; 6(4):363-371.

Molassiotis A, Cheng HL, Leung KT, Li YC, Wong KH, Au JSK, Sundar R, Chan A, Ng TRD, Suen LKP, Chan CW, Yorke J, Lopez V. Risk factors for chemotherapy-induced peripheral neuropathy in patients receiving taxane- and platinum-based chemotherapy. Brain & Behavior 2019; 9(6):e01312. [Impact factor: 2.091]

Yeo F, Ng CC, Loh KWJ, Molassiotis A, Cheng HL, Au JSK, Leung KT, Li YC, Wong KH, Suen L, Chan CW, Yorke J, Farrell C, Bandla A, Ang E, Lopez V, Sundar R, Chan A. Minimal clinically important difference of the EORTC QLQ-CIPN20 for worsening peripheral neuropathy in patients receiving neurotoxic chemotherapy. Supportive Care in Cancer. 2019; 27(12):4753-4762. [Impact factor: 2.635]

Molassiotis A; Cheng HL; Lopez V; Au JSK; Chan A; Bandla A; Leung KT; Li YC; Wong KH; Suen LKP; Chan CW; Yorke J; Farrell C; Sundar R. Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy. BMC Cancer 2019;19(1):132. doi: 10.1186/s12885-019-5302-4. [Impact factor: 3.15]

Molassiotis A, Suen L, Lai C, Chan B, Wat KHY, Tang J, To KL, Leung CO, Lee S, Lee P, Chien WT. The effectiveness of acupressure in the management of depressive symptoms and in improving quality of life in older people living in the community: a randomised sham-controlled trial. Aging & Mental Health. 2019 Mar 14:1-9. doi: 10.1080/13607863.2019.1584789. [Epub ahead of print] [Impact factor: 2.478]

Ericsson A, Kumlien C, Ching S, Carlson E, Molassiotis A. Impact on Quality of Life of Men with Screening-Detected Abdominal Aortic Aneurysms Attending Regular Follow ups: A Narrative Literature Review. European Journal of Vascular & Endovascular Surgery. 2019; 57(4):589-596. [Impact factor: 5.328]

Xing W, So WKW, Choi KC, Wong CL, Tong M, Choy YP, Molassiotis A, Yates P, Chan RJ. Translation and psychometric testing of Cancer Survivors' Unmet Needs, Chinese version. Asia Pacific Journal of Clinical Oncology. 2019; 15(5):e142-e146. [Impact factor: 2.012]

Harle ASA, Blackhall FH, Molassiotis A, Yorke J, Dockry R, Holt K, Yuill D, Baker K, Smith JA. Cough in patients with lung cancer: a longitudinal observational study of characterisation and clinical associations. Chest 2019; 155(1):103-113. [Impact factor: 8.308]

Cheng HL, Molassiotis A. Longitudinal validation and comparison of the Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life-Chemotherapy-Induced Peripheral Neuropathy Questionnaire (EORTC QLQ-CIPN20) and the Functional Assessment of Cancer-Gynecologic Oncology Group-Neurotoxicity subscale (FACT/GOG-Ntx). Asia Pacific Journal of Clinical Oncology. 2019, 15 (1): 56-62. [Impact factor: 2.012]

Li Q, Lin Y, Xu Y, Molassiotis A. Cancer survivorship care after curative treatment: Chinese oncology practitioners’ practices. Supportive Care in Cancer 2019, 27(4): 1287–1298. [Impact factor: 2.635]

Chan CW, Cheng HL, Au SK, Leung KT, Li YC, Wong K, Molassiotis A. Living with chemotherapy-induced peripheral neuropathy: Uncovering the symptom experience and self-management of neuropathic symptoms among cancer survivors European Journal of Oncology Nursing 2018, 36: 135-141. [Impact factor: 1.876]

Wang T, Molassiotis A, Chung BPM, Tan JY. Current Research Status of Palliative Care in Mainland China. Journal of Palliative Care. 2018; 33(4):215-241. [Impact factor: 1.2]

Wang T, Molassiotis A, Chung BPM, Tan JY. Unmet care needs of advanced cancer patients and their informal caregivers: a systematic review. BMC Palliative Care. 2018; 17(1):96. doi: 10.1186/s12904-018-0346-9. [Impact factor: 2.015]

Lee R, Yeo ST, Rogers SN, Caress AL, Molassiotis A, Ryder D, Sanghera P, Lunt C, Scott B, Keeley P, Edwards RT, Slevin N. Randomised feasibility study to compare the use of Therabite® with wooden spatulas to relieve and prevent trismus in patients with cancer of the head and neck. British Journal of Oral & Maxillofacial Surgery. 2018; 56(4):283-291. [Impact factor: 1.061]

Lee R, Molassiotis A, Rogers SN, Edwards RT, Ryder D, Slevin N. Protocol for the trismus trial-therabite versus wooden spatula in the amelioration of trismus in patients with head and neck cancer: randomised pilot study. BMJ Open. 2018; 8(3):e021938. doi: 10.1136/bmjopen-2018-021938. [Impact factor: 2.496]

Molassiotis A, Roberts S, Cheng HL, To HKF, Ko PS, Lam W, Lam YF, Abbott J, Kiefer D, Sanmugarajah J, Marshall AP. Partnering with families to promote nutrition in cancer care: feasibility and acceptability of the PIcNIC intervention. BMC Palliative Care. 2018 Mar 20;17(1):50. doi: 10.1186/s12904-018-0306-4. [Impact factor: 2.015]

Herrstedt J, Summers Y, Daugaard G, Christensen TB, Holmskov K, Taylor PD, Fox GM, Molassiotis A. Amisulpride in the prevention of nausea and vomiting induced by cisplatin-based chemotherapy: a dose-escalation study. Supportive Care in Cancer. 2018; 26(1):139-145. [Impact factor: 2.635]

Davies LM, Hayhurst KP, Lorigan P, Molassiotis A. Unmet supportive care needs, health status and minimum costs in survivors of malignant melanoma. European Journal of Cancer Care. 2018; 27(2):e12811. doi: 10.1111/ecc.12811 [Impact factor: 2.161]

Ho GWK, Bressington D, Leung SF, Lam KKC, Leung AYM, Molassiotis A, Ligot J, Ranoco C, Sophal C, Valimaki M. Depression literacy and health-seeking attitudes in the Western Pacific region: a mixed-methods study. Social Psychiatry & Psychiatric Epidemiology. 2018; 53(10):1039-1049. [Impact factor: 3.335]

Tan JY, Molassiotis A, Lloyd Williams M, Yorke J. Burden, Emotional Distress and Quality of Life among Informal Caregivers of Lung Cancer Patients: An Exploratory Study. European Journal of Cancer Care 2018; 27(1). doi: 10.1111/ecc.12691. [Impact factor: 2.161]

Molassiotis A, Yates P, Li Q, So WKW, Pongthavornkamol K, Pittayapan P, Komatsu H, Thandar M, Li MS, Titus Chacko S, Lopez V, Butcon J, Wyld D, Chan RJ; STEP Study Collaborators. Mapping unmet supportive care needs, quality-of-life perceptions and current symptoms in cancer survivors across the Asia-Pacific region: results from the International STEP Study. Annals of Oncology. 2017; 28(10):2552-2558. [Impact factor: 18.274]

Chan RJ, Yates P, Li Q, Komatsu H, Lopez V, Thandar M, Chacko ST, So WKW, Pongthavornkamol K, Yi M, Pittayapan P, Butcon J, Wyld D, Molassiotis A; STEP study collaborators. Oncology practitioners' perspectives and practice patterns of post-treatment cancer survivorship care in the Asia-Pacific region: results from the STEP study. BMC Cancer. 2017; 17(1):715. doi: 10.1186/s12885-017-3733-3. [Impact factor: 3.15]

Van Vu D, Molassiotis A, Ching SSY, Le TT. Effects of Qigong on symptom management in cancer patients: A systematic review. Complementary Therapies in Clinical Practice. 2017; 29:111-121. [Impact factor: 1.770]

Farrell C, Walshe C, Molassiotis A. Are nurse-led chemotherapy clinics really nurse-led? An ethnographic study. International Journal of Nursing Studies. 2017; 69:1-8. [Impact factor: 3.783]

Dranitsaris G, Molassiotis A, Clemons M, Roeland E, Schwartzberg L, Dielenseger P, Jordan K, Young A, Aapro M. The development of a prediction tool to identify cancer patients at high risk for chemotherapy-induced nausea and vomiting. Annals of Oncology 2017, 28: 1260-1267. [Impact factor: 18.274]

Molassiotis A, Smith JA, Mazzone P, Blackhall F, Irwin RS; Chest Expert Cough Panel. Symptomatic Treatment of Cough Among Adult Patients With Lung Cancer: CHEST Guidelines and Expert Panel Report. Chest. 2017, 151: 861-874. [Impact factor: 8.308]

Ruhlmann CH, Jahn F, Jordan K, Dennis K, Maranzano E, Molassiotis A, Roila F, Feyer P. 2016 updated MASCC/ESMO consensus recommendations: prevention of radiotherapy-induced nausea and vomiting. Supportive Care in Cancer. 2017, 25: 309-316. [Impact factor: 2.635]

Dupuis LL, Sung L, Molassiotis A, Orsey AD, Tissing W, van de Wetering M. 2016 updated MASCC/ESMO consensus recommendations: Prevention of acute chemotherapy-induced nausea and vomiting in children. Supportive Care in Cancer. 2017, 25: 323-331. [Impact factor: 2.635]

Walsh D, Davis M, Ripamonti C, Bruera E, Davies A, Molassiotis A. 2016 Updated MASCC/ESMO consensus recommendations: Management of nausea and vomiting in advanced cancer. Supportive Care in Cancer. 2017, 25: 333-340. [Impact factor: 2.635]

Dupuis LL, Roscoe JA, Olver I, Aapro M, Molassiotis A. 2016 updated MASCC/ESMO consensus recommendations: Anticipatory nausea and vomiting in children and adults receiving chemotherapy. Supportive Care in Cancer. 2017, 25: 317-321. [Impact factor:2.635]

Molassiotis A, Aapro M, Herrstedt J, Gralla R, Roila F. MASCC/ESMO Antiemetic Guidelines: Introduction to the 2016 guideline update. Supportive Care in Cancer. 2017, 25: 323-331. [Impact factor: 2.635]

Roila F, Molassiotis A, Herrstedt J, Aapro M, Gralla RJ, Bruera E, Clark-Snow RA, Dupuis LL, Einhorn LH, Feyer P, Hesketh PJ, Jordan K, Olver I, Rapoport BL, Roscoe J, Ruhlmann CH, Walsh D, Warr D, van der Wetering M; participants of the MASCC/ESMO Consensus Conference Copenhagen 2015. 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients. Annals of Oncology. 2016; 27 (suppl 5): v119-v133. [Impact factor:18.274]

Molassiotis A, Lee PH, Burke TA, Roila F, Gascon P, Dicato M, Aapro M. Anticipatory nausea, risk factors and its impact on chemotherapy-related nausea and vomiting: results from the Pan European Emesis Registry Study. Journal of Pain and Symptom Management 2016, 51(6):987-993. [Impact factor:3.077]

Burden ST, Stamataki Z, Hill J, Molasiotis A, Todd C. An exploration of food and the lived experience of individuals after treatment for colorectal cancer using a phenomenological approach. Journal of Human Nutrition & Dietetics. 2016; 29(2):137-45. [Impact factor: 3.146]

Johnson M, Close L, Gillon SC, Molassiotis A, Lee PH, Farquhar MC. Use of the modified Borg scale and Numerical Rating Scale to measure chronic breathlessness: a pooled data analysis. European Respiratory Journal 2016, 47(6):1861-1864. [Impact factor: 12.339]

Yorke J, Lloyd-Williams M, Smith J, Blackhall F, Harle A, Warden J, Ellis J, Pilling M, Haines J, Luker K, Molassiotis A. Management of the respiratory distress symptom cluster in lung cancer: a randomised controlled feasibility trial. Supportive Care in Cancer. 2015 23(11):3373-3384. [Impact factor: 2.635]

Wong FK, Liu H, Wang H, Anderson D, Seib C, Molasiotis A. Global Nursing Issues and Development: Analysis of World Health Organization Documents. Journal of Nursing Scholarship. 2015; 47(6):574-83. [Impact factor:2.655]

Molassiotis A, Bailey C, Caress A, Tan JY. Interventions for cough in cancer. Cochrane Database of Systematic Reviews 2015 May 19;5:CD007881 [Impact factor: 7.890]

Molassiotis A; Charalambous A; Taylor P; Stamataki Z; Summers Y. The effect of resistance inspiratory muscle training in the management of breathlessness in patients with thoracic malignancies: a feasibility randomised trial. Supportive Care in Cancer 2015, 23: 1637-1645. [Impact factor: 2.635]

Molassiotis A, Uyterlinde W, Hollen PJ, Sarna L, Palmer P, Krishnasamy M. Supportive care in lung cancer: Milestones over the past 40 years. Journal of Thoracic Oncology. 2015, 10: 10-18. [Impact factor: 13.357]